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Abstract
Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular
dystrophy. The major symptoms of this condition are walking difficulties, dyspnea caused by
progressive skeletal muscle weakness, and cardiomyopathy. Recent advances in ventilator
support devices have dramatically decreased mortality caused by respiratory distress. Con-
sequently, cardiomyopathy resulting in heart failure is currently the major cause of death
among DMD patients. One mechanism by which skeletal muscle is damaged in DMD
patients involves elevation of the intracellular Ca2+ concentration. By contrast, the mecha-
nisms underlying the development of cardiomyopathy are unclear. To investigate this, we
examined the intracellular Ca2+ concentration and calcium transients in cardiomyocytes dif-
ferentiated from human induced pluripotent stem cells (hiPSCs). hiPSCs were derived from
a DMD patient (DMD-hiPSCs), in whom exon 44 of the gene encoding dystrophin was
deleted, and from his parents (control-hiPSCs), who did not carry this mutation. The intracel-
lular Ca2+ concentration was measured using the fluorescent indicator indo-1. The fluores-
cence ratio (410/490 nm) of indo-1 at rest (R0), the peak of this ratio (Rmax), and the
amplitude (Rmax—R0) were significantly higher in cardiomyocytes differentiated from DMD-
hiPSCs than in those differentiated from control-hiPSCs. Moreover, mechanical stretching
significantly increased the intracellular Ca2+ concentration in cardiomyocytes differentiated
from DMD-hiPSCs, but not in those differentiated from control-hiPSCs. These findings indi-
cate that elevation of the intracellular Ca2+ concentration can cause cardiac damage leading
to cardiomyopathy in DMD patients.
Introduction
Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dys-
trophy. This condition is caused by mutations of the gene encoding dystrophin located on
chromosome Xp21 and is inherited in an autosomal recessive manner. DMD is relatively
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common, with an incidence of approximately 1 per 3500 male births. Muscle atrophy and
weakness develop progressively with repeated cycles of muscle degeneration and regeneration.
The majority of patients begin to experience walking difficulties before puberty. Patients usu-
ally develop respiratory muscle failure and heart failure, which are both common lethal com-
plications of DMD, in their late teens and early twenties [1].
Until about 1990, respiratory insufficiency and respiratory tract infections were the major
causes of death among DMD patients [2–4]. However, this changed after the development of
ventilator support devices, such as nocturnal home ventilation [5,6]. The mean lifespan of
non-ventilated DMD patients was 14.4 years in the 1960s, whereas that of ventilated DMD
patients was 25.3 years in the 1990s [6], and it is currently 36.23 years. Cardiomyopathy is now
the major cause of death among DMD patients. The percentage of DMD patients dying from
cardiac problems increased from 8% to 44% after the 1990s [7].
Cardiomyopathy associated with fibrosis usually leads to dilated cardiomyopathy (DCM).
In total, 25% and 59% of DMD patients aged less than 6 years and 6–10 years have a sub-clini-
cal stage of DCM, respectively [8]. More than 80% of DMD patients older than 18 years have
reduced cardiac functions [9,10]. Moreover, 90% of DMD patients develop DCM [1].
Patients with DMD lack dystrophin, a major structural protein in muscle cells. Dystrophin
links the cytoskeleton with the extracellular matrix in muscles [11]. Muscle contraction leads
to rupture of the sarcolemma in mdx mice, an animal model of DMD [12]. In addition, Franco
et al. reported that muscles of mdx mice contain mechano-transducing ion channels that open
in response to stretching, leading to abnormal leakage of Ca2+ into cells [13]. Elevation of the
intracellular Ca2+ concentration is thought to be important for the initiation of skeletal muscle
damage in DMD patients based on findings obtained using mdx mice [14]. An elevated Ca2+
concentration leads to cell damage in these mice [15,16]. Abnormal handling of intracellular
Ca2+ is also observed in cardiomyocytes of patients with end-stage heart failure [17].
Here, we investigated the development of cardiomyopathy in DMD patients by examining
calcium transients in cardiomyocytes differentiated from human induced pluripotent stem
cells (hiPSCs).
Materials and methods
Generation of hiPSCs from fibroblasts
Human iPS cells experiments were approved by the Ethics Committee of Kyoto University
(approval number: R0091, G259), and it was conducted according to the principles expressed
in the Declaration of Helsinki. A written informed consent was obtained from the parents.
hiPSCs were established by transducing fibroblasts obtained from a DMD patient and his
parents with Yamanaka factors (Oct3/4, Sox2, Klf4, and c-Myc). These hiPSCs were maintained
on dishes coated with Matrigel (14.6 μg/cm2; Becton, Dickinson and Company) in mTeSR1
(Stem Cell Technologies) and passaged every 4–5 days. Cells were treated with 5 mM Y-27632
(Nacalai Tesque), a ROCK inhibitor, for 1 day after passage to prevent apoptosis.
Differentiation and purification of cardiomyocytes
Differentiation of hiPSCs into cardiomyocytes was induced by the matrix sandwich method as
previously described [18,19] with some modifications. Briefly, hiPSCs derived from the DMD
patient (DMD-hiPSCs) and his parents (control-hiPSCs) were passaged onto 12-well plates
coated with growth factor-reduced Matrigel (8.7 μg/cm2; Becton, Dickinson and Company) in
mTeSR1 (Stem Cell Technologies). Cells were overlaid with growth factor-reduced Matrigel
when they reached 80–90% confluency. On day 5 of differentiation, the culture medium was
replaced by RPMI medium (Invitrogen) containing B27 supplement (Invitrogen) and 100 ng/
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mL Dkk-1 (R&D Systems) for 2 days. After approximately 30–40 days, cardiomyocytes were
purified by magnetic-activated cell sorting (Miltenyi Biotec K.K.) using an antibody against
vascular cell adhesion molecule-1 (BioLegend).
PCR analysis
Genomic DNA was isolated from fibroblasts obtained from the DMD patient and his parents.
Exons 43, 44, and 45 of the gene encoding dystrophin were analyzed by PCR. The cycling con-
ditions were as follows: 40 cycles of denaturation at 95˚C for 5 min, annealing at 55˚C for 30
sec, and extension at 72˚C for 1 min, and a final extension at 72˚C for 7 min. The following
primers were used: 43 forward, tgc aac acc att tgc tac c; 43 reverse, atc att
tct gca agt atc aag; 44 forward, gtt act tga aac taa act ctg caa atg;
44 reverse, aca aca aca gtc aaa agt aat ttc cat c; 45 forward, ttc ttt gcc
agt aca act gc; and 45 reverse, tct gct aaa atg ttt tca ttc c.
Immunostaining
Cells were fixed in phosphate buffered saline (PBS) containing 4% paraformaldehyde for 15
min at room temperature, washed with PBS, and treated with PBS containing 0.1% Triton X-
100 and 5% goat or donkey serum for 30 min at room temperature. Thereafter, cells were
stained with the following primary antibodies for 1 h at room temperature or overnight at 4˚C:
anti-NANOG (1:100, R&D Systems), anti-TRA-1-81 (1:100, Millipore), anti-cardiac troponin
T (cTnT; 1:200, Thermo Scientific), and anti-dystrophin (1:100, MANDRA1, Sigma-Aldrich).
Next, cells were stained with the following secondary antibodies for 1 h at room temperature:
Cy3-conjugated donkey anti-mouse IgM (1:500, Jackson ImmunoResearch), Alexa Fluor
488-conjugated donkey anti-goat IgG (1:500, Invitrogen), Alexa Fluor 568-conjugated donkey
anti-mouse IgG (1:500, Invitrogen) and a Zenon Alexa Fluor 488 labelling kit (Invitrogen).
Nuclei were counterstained with 10 μg/mL Hoechst 33342 (Invitrogen). Images were acquired
using a fluorescence microscope (BZ-X700 or BZ-X710, Keyence). Confocal images were cap-
tured by TCS SP8 confocal microscope (Leica Microsystems).
Karyotypes
The karyotype of each hiPSC line was analyzed by Nihon Gene Research Laboratories Inc.
RT-PCR
Total RNA was isolated from hiPSCs using an RNeasy Mini Kit (Qiagen) and treated with
DNase. Thereafter, 1 μg of total RNA was reverse-transcribed into cDNA using an Omniscript
RT Kit (Qiagen). Quantitative PCR analysis of Oct3/4, Sox2, Klf4, and c-Myc was performed
on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems) using SYBR Pre-
mix Ex Taq II (Takara Bio). The established human embryonic stem cell line KhES-1 [20] was
analyzed as a control.
Teratoma formation
Animal experiments were approved by the Institutional Review Board (IRB) of Kyoto Univer-
sity (approval number: Med Kyo 12556). Undifferentiated hiPSCs were treated with collage-
nase IV (Invitrogen), collected in tubes, and centrifuged. The pellets were resuspended in
mTeSR1 (Stem Cell Technologies) containing 5 mM Y-27632 (Nacalai Tesque). Under general
anesthesia with Sevoflurane, approximately 3 million cells were injected into the testis of a
NOD/scid/γc null mouse (Central Institute for Experimental Animals). Eight weeks later,
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tumors were harvested after euthanasia by carbon dioxide, dissected into 1 cm3 cubes, and
fixed in PBS containing 4% paraformaldehyde. Paraffin-embedded tissue was sliced and
stained with hematoxylin and eosin.
Measurement of the intracellular Ca2+ concentration
The intracellular Ca2+ concentration was measured using the fluorescent indicator indo-1
(Dojindo Molecular Technologies) and a video image analysis system (AQUACOSMOS,
Hamamatsu Photonics). Cardiomyocytes differentiated from hiPSCs were re-plated onto 12
mm glass bottom dishes (Iwaki) and incubated for 2–3 days to allow cell adhesion. Thereafter,
cells were loaded with 3 μM indo-1 for 30 min. Prior to recording, the dish was washed with
PBS and filled with Tyrode’s salt solution (Sigma-Aldrich). The fluorescence ratio (410/490
nm) of indo-1 was plotted along the y axis. This ratio at rest (R0), the peak of this ratio (Rmax),
and the amplitude (Rmax—R0) were measured.
Mechanical stretching of cultured cardiomyocytes
To expose cardiomyocytes to mechanical stress, cardiomyocytes differentiated from hiPSCs
were re-plated onto fibronectin-coated silicone chambers (Strex Inc.) and incubated for 2–3
days to allow cell adhesion. Thereafter, mechanical stress was induced by mechanically stretch-
ing cardiomyocytes (120% elongation) at a frequency of 60 cycles per min using an automatic
stretching system STB-140 (Strex Inc.). The intracellular Ca2+ concentration was recorded
prior to and 3 h after stretching by measuring indo-1 fluorescence.
Statistical analysis
Results are presented as mean ± standard error of the mean. Statistical analyses were per-
formed using a one-way ANOVA followed by the Tukey-Kramer test with JMP1 Pro (11.0.0)
software. p values less than 0.05 were considered statistically significant.
Results
Clinical history of the DMD patient and generation of hiPSCs
A 3-year-old boy diagnosed with DMD presented to our hospital. He had undergone an ade-
noidectomy at 2 years of age. A preoperative blood test demonstrated that his levels of serum
muscle enzymes (i.e., aspartate aminotransferase, alanine aminotransferase, and creatine phos-
phokinase) were significantly elevated, indicative of a muscular disease. Genetic analysis
revealed that exon 44 of the gene encoding dystrophin was deleted in the patient. There was no
family history of muscular diseases, and the patient’s parents did not carry mutations of this
gene. Deletion of exon 44 was confirmed by PCR analysis of cultured fibroblasts isolated from
the patient (Fig 1A). This is a high-risk deletion that leads to lethal DCM[21]. The cardiac
function of the patient gradually deteriorated, and he started taking anti-heart failure drugs
when 11 years old.
hiPSCs were generated by retrovirally transducing fibroblasts isolated from the skin of the
patient and his parents with Oct3/4, Sox2, Klf4, and c-Myc. These hiPSCs formed colonies, and
all cells were cuboid and tightly packed in each colony (Fig 1B). We established two hiPSC
lines derived from the patient (DMD-1 and DMD-2), one derived from his father (Con-1),
and one derived from his mother (Con-2).
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hiPSCs are pluripotent in vitro and in vivo
The generated hiPSCs were characterized by immunostaining for pluripotency markers, kar-
yotyping, assessing exogenous gene silencing, and examining teratoma formation. All the
hiPSC lines expressed NANOG and TRA-1-81 (Fig 2A) and had a normal karyotype (Fig 2B).
Quantitative PCR analysis demonstrated that all the exogenous genes were silenced in each
hiPSC line, with the exception of Oct3/4 and Klf4 in Con-2 hiPSCs (Fig 2C). Hematoxylin and
eosin staining showed that each hiPSC line differentiated into all three germ layers (endoderm,
mesoderm, ectoderm) in vivo (Fig 3). Although exogenous Oct3/4 and Klf4 were still expressed
in Con-2 hiPSCs, expression of endogenous Oct3/4 and Klf4 was increased in these cells and
they formed teratomas. Thus, all the hiPSC lines were undifferentiated and pluripotent.
Cardiomyocytes differentiated from hiPSCs express mature cardiac
markers
The hiPSC lines were differentiated into cardiomyocytes, and these cells were purified by mag-
netic-activated cell sorting using an antibody against vascular cell adhesion molecule-1. The
cardiomyocytes expressed cTnT and displayed sarcomeric structures (Fig 4A). Staining with
an anti-dystrophin antibody demonstrated that dystrophin was present mainly on cytoplasmic
membranes of cardiomyocytes differentiated from Con-1 and -2 hiPSCs, but not in the cytosol
of cardiomyocytes differentiated from DMD-1 and -2 hiPSCs (Fig 4B). These results indicate
that cardiomyocytes differentiated from DMD-1 and -2 hiPSCs structurally recapitulate those
found in DMD patients.
The intracellular Ca2+ concentration is elevated in cardiomyocytes
differentiated from DMD-hiPSCs
The intracellular Ca2+ concentration was measured using the fluorescent indicator indo-1.
Representative calcium transients of cardiomyocytes derived from DMD- and control-hiPSCs
are shown in Fig 5A. During the recording, beat rates of DMD-1, DMD-2, Con-1 and Con-2
cardiomyocytes were 8.5±2.1, 20.9±2.1, 9.6±1.3, 5.7±1.4 per minute, respectively. The fluores-
cence ratio (490/410 nm) of indo-1 indicates the intracellular Ca2+ concentration, and the
curve represents the change in this concentration. The indo-1 fluorescence ratio at rest (R0),
the peak of this ratio (Rmax), and the amplitude (Rmax—R0) were significantly higher in
Fig 1. Mutational analysis and generation of hiPSCs. (A) PCR analysis of exons 43, 44, and 45 of the gene encoding
dystrophin in fibroblasts. Fa, father; Mo, mother; and Pt, patient. (B) Morphology of a colony of DMD-hiPSCs. Scale bar:
100 μm.
https://doi.org/10.1371/journal.pone.0213768.g001
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Fig 2. Characterization of hiPSCs. (A) Immunostaining of the pluripotency markers NANOG (green) and TRA-1-81 (red)
in hiPSCs. Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 20 μm. (B) Karyotyping of hiPSCs. (C)
Quantitative PCR analysis of total and exogenous Oct3/4, Sox2, Klf4, and c-Myc expression in hiPSCs. Black and white bars
indicate total and exogenous gene expression, respectively. ESC: human embryonic stem cell, NC: negative control (water).
https://doi.org/10.1371/journal.pone.0213768.g002
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cardiomyocytes differentiated from DMD-1 and -2 hiPSCs than in those differentiated from
Con-1 and -2 hiPSCs (Fig 5Ba–5Bc). R0 of DMD-1, DMD-2, Con-1 and Con-2 cardiomyocytes
were 1.26±0.10, 1.40±0.10, 0.83±0.06, 0.93±0.06 (mean ± SE), respectively. Rmax of DMD-1,
DMD-2, Con-1 and Con-2 cardiomyocytes were 2.40±0.21, 2.88±0.21, 1.56±0.13, 1.49±0.14
(mean ± SE), respectively. Amplitude of DMD-1, DMD-2, Con-1 and Con-2 cardiomyocytes
were 1.15±0.13, 1.48±0.13, 0.74±0.08, 0.57±0.08 (mean ± SE), respectively. There was no cor-
relation between beat rate and R0, Rmax, Amplitude by calculating correlation coefficients
(HR and R0 (p = 0.0965), HR and Rmax (p = 0.6744), HR and Amplitude (p = 0.5900). Next,
Fig 3. Formation of teratomas by hiPSCs. Hematoxylin and eosin staining demonstrated that teratomas formed by each
hiPSC line contained all three germ layers. Gut-like tissues are observed in each endoderm panel. Muscular tissues are
observed in the mesoderm panels of DMD-1 hiPSCs, while cartilage tissues are observed in those of DMD-2, Con-1, and
Con-2 hiPSCs. Neural rosette formation is observed in each ectoderm panel. Scale bar: 50 μm.
https://doi.org/10.1371/journal.pone.0213768.g003
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Fig 4. Immunostaining of cardiomyocytes differentiated from hiPSCs. (A) (a—d) Cardiomyocytes differentiated
from hiPSCs expressed cTnT (green). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar: 20 μm. (a-i—
d-iv) Magnified images in red squares in panels of (a—d). (B) Immunostaining of dystrophin (red) and cTnT (green).
Dystrophin was not detected in cardiomyocytes differentiated from DMD-1 and -2 hiPSCs. Nuclei were
counterstained with Hoechst 33342 (blue). Scale bar: 20 μm.
https://doi.org/10.1371/journal.pone.0213768.g004
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cardiomyocytes differentiated from DMD-1, -2 and Con-1, -2 hiPSCs were mechanically
stretched to investigate basal intracellular Ca2+ concentration and intracellular Ca2+ reactions
to mechanical stress. Stretching significantly increased the indo-1 fluorescence ratio at rest
(R0) and the peak of the ratio (Rmax) in cardiomyocytes differentiated from DMD-1 and -2
hiPSCs, but not in cardiomyocytes differentiated from Con-1 and -2 hiPSCs (Fig 6a–6c). How-
ever, amplitude (Rmax—R0) was significant difference only in cardiomyocytes differentiated
Fig 5. Measurement of the intracellular Ca2+ concentration using the fluorescent indicator Indo-1. (A) Representative
calcium transients. The fluorescence ratio (410/490 nm) of indo-1 is plotted along the y axis. This ratio at rest (R0), the peak of
this ratio (Rmax), and the amplitude (Rmax—R0) were measured. (B) Intracellular Ca
2+ concentration. The indo-1 fluorescence
ratio (410/490 nm) at rest (R0), the peak of this ratio (Rmax), and the amplitude (Rmax—R0) were measured in cardiomyocytes.
n = 12 (DMD-1), n = 12 (DMD-2), n = 30 (Con-1), and n = 28 (Con-2). �, p<0.05.
https://doi.org/10.1371/journal.pone.0213768.g005
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Fig 6. The intracellular Ca2+ concentration before and after mechanical stretching. The fluorescence ratio (410/490 nm) of
indo-1 at rest (R0), the peak of this ratio (Rmax), and the amplitude (Rmax—R0) were measured before and after mechanical
stretching. n = 26 (DMD-1), n = 16 (DMD-1 Stretch), n = 32 (DMD-2), n = 30 (DMD-2 Stretch), n = 26 (Con-1), and n = 14
(Con-1 Stretch), n = 30 (Con-2), and n = 16 (Con-2 Stretch). ��, p<0.01; �, p<0.05; and N.S., not significant.
https://doi.org/10.1371/journal.pone.0213768.g006
Elevated Ca2+ concentration in cardiomyocytes differentiated from DMD-hiPSCs
PLOS ONE | https://doi.org/10.1371/journal.pone.0213768 March 15, 2019 10 / 13
from DMD-2 hiPSCs. R0 of DMD-1, DMD-1 stretch, DMD-2, DMD-2 stretch, Con-1, Con-1
stretch, Con-2 and Con-2 stretch cardiomyocytes were 0.97±0.05, 1.29±0.06, 0.82±0.05,
1.33±0.05, 0.87±0.05, 0.87±0.07, 0.75±0.05, 0.80±0.06 (mean ± SE), respectively. Rmax of
DMD-1, DMD-1 stretch, DMD-2, DMD-2 stretch, Con-1, Con-1 stretch, Con-2 and Con-2
stretch cardiomyocytes were 1.56±0.09, 2.06±0.11, 1.40±0.08, 2.29±0.08, 1.34±0.09, 1.43±0.12,
1.44±0.08, 1.46±0.11 (mean ± SE), respectively. Amplitude of DMD-1, DMD-1 stretch, DMD-
2, DMD-2 stretch, Con-1, Con-1 stretch, Con-2 and Con-2 stretch cardiomyocytes were
0.59±0.06, 0.77±0.07, 0.58±0.05, 1.03±0.05, 0.47±0.06, 0.56±0.08, 0.69±0.05, 0.66±0.07
(mean ± SE), respectively. These results indicate that the intracellular Ca2+ concentration,
especially basal concentration, is much higher in cardiomyocytes differentiated from DMD-
hiPSCs than in those differentiated from control-hiPSCs. Moreover, this difference is larger
after stretching than before stretching only in cardiomyocytes differentiated from DMD-
hiPSCs.
Discussion
DMD is the most common and severe form of muscular dystrophy. Patients with this condi-
tion lack dystrophin, a major structural protein in muscle cells. Muscular atrophy resulting in
muscle weakness develops progressively. DMD can also lead to DCM. Recent reports revealed
that the percentage of DMD patients who die due to cardiac problems has rapidly increased,
while the percentage who die due to respiratory complications has concomitantly decreased.
Dystrophin links the cytoskeleton with the extracellular matrix in muscles [10], which helps
to maintain the shape of muscle cells. Consequently, changes in muscle cell morphology were
thought to mainly underlie the progressive muscle weakness observed in DMD patients.
Repeated stretch-contraction cycles were considered to cause rupture of the sarcolemma [11].
However, recent studies of mdx mice revealed another mechanism underlying progressive
skeletal muscle weakness in DMD patients. The absence of dystrophin disrupts signal trans-
duction to a type of mechano-transducing ion channel and consequently muscle stretching
leads to abnormal leakage of Ca2+ into skeletal muscle cells [12]. Elevation of the intracellular
Ca2+ is thought to be important for initiation of the pathogenesis of DMD [13] and damages
cells [14,15]. Abnormal handling of Ca2+ is observed in patients with end-stage heart failure
[16]. The severity of cardiomyopathy does not correlate with the severity of skeletal muscle
damage in all DMD patients[22]. To investigate the mechanisms by which cardiomyopathy
develops in DMD patients, we measured the intracellular Ca2+ basal concentration and change
in cardiomyocytes differentiated from DMD-hiPSCs, which recapitulated the phenotypes of
DMD in vitro. Exon 44 of the gene encoding dystrophin was deleted in the DMD patient,
which causes severe DCM[21].
hiPSCs were first generated by Yamanaka et al. in 2007[23]. These cells are promising tools
not only for regenerative medicine, but also for developing in vitro disease models, investigat-
ing the pathogenesis of diseases, and discovering new drugs[24]. In addition, hiPSCs can be
easily differentiated into various cell types in vitro.
Measurement of the fluorescence ratio (410/490 nm) of indo-1 demonstrated that the intra-
cellular Ca2+ concentration was much higher in cardiomyocytes differentiated from DMD-
hiPSCs than in those differentiated from control-hiPSCs. This result is similar to the findings
of a previous report concerning skeletal muscle of mdx mice [12]. Mechanical stretching
increased the intracellular Ca2+ concentration in cardiomyocytes differentiated from DMD-
hiPSCs, but not in those differentiated from control-hiPSCs. Especially, the elevation of R0
value means that reticulums in cardiomyocytes cannot fully re-intake the Ca2+ which was
emitted during contraction phase. Under this idea, DMD cardiomyocytes have diastolic
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dysfunction, because their R0 value is higher than R0 value of control cardiomyocytes both
before and after mechanical stretch stress. Given the previous report of a relationship between
calcium transients and heart failure [16], calcium transients in cardiomyocytes may trigger
cardiomyopathy in DMD patients.
In conclusion, calcium overload is one way by which cardiomyopathy develops in DMD
patients. Modulation of calcium transients in cardiomyocytes may be a useful strategy to treat
cardiomyopathy in DMD patients and thereby improve their prognosis.
Conclusion
Calcium overload might be one mechanism by which cardiomyopathy develops in DMD
patients. Reducing calcium overload is a potential strategy to treat cardiomyopathy in such
patients.
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